Monoclonal Technologies, Inc. – Trademark Portfolio
Entity Type: 03
Monoclonal Technologies, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include M-TECH. The owner is based in Norcross, GA.
6500 McDonough Drive
Norcross, GA 30093
Showing of trademarks Trademarks
Trademark Classifications
Monoclonal Technologies, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Monoclonal Technologies, Inc. have?
Monoclonal Technologies, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does Monoclonal Technologies, Inc. file in?
Monoclonal Technologies, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Monoclonal Technologies, Inc.'s most well-known trademarks?
Monoclonal Technologies, Inc.'s registered trademark portfolio includes well-known marks such as M-TECH. These are among 1 currently registered trademark in the portfolio.
What is Monoclonal Technologies, Inc.'s trademark registration success rate?
Monoclonal Technologies, Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.